Viewing Study NCT01463059


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-02-06 @ 9:27 AM
Study NCT ID: NCT01463059
Status: COMPLETED
Last Update Posted: 2013-03-25
First Post: 2011-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Sponsor: UCB Japan Co. Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid Arthritis View
None Monoclonal Antibody View
None Interleukin-6 View
None Olokizumab View
None CDP6038 View